CytomX Therapeutics

Early-stage biotechnology company developing probodies, proteolytically-activated antibodies.

HQ location

South San Francisco, United States

Website

Launch date

2008

Employees

Market cap

Enterprise value

$190m

Share price

$2.05 CTMX

Jobs

View job openings

Recent deals

Ardais Corporation

https://twitter.com/cytomxinc https://www.linkedin.com/company/cytomx-therapeutics

Authorizing premium user...